Corticosteroids do not alter the threshold for vertebral fracture

Journal of Bone and Mineral Research

Volumn 15, Issue 5, 2000, Pages 952-956

  Selby, Peter L ^a,b   Halsey, J P ^c   Adams, K R H ^d   Klimiuk, P ^e   Knight, S M ^f   Pal, B ^g   Stewart, I M ^h   Swinson, D R ⁱ  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^c ROYAL LANCASTER INFIRMARY   (United Kingdom)

^d Bolton Royal Infirmary   (United Kingdom)

^e ROYAL OLDHAM HOSPITAL   (United Kingdom)

^f MACCLESFIELD DISTRICT GENERAL HOSPITAL   (United Kingdom)

^g MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^h BLACKPOOL VICTORIA HOSPITAL   (United Kingdom)

ⁱ WRIGHTINGTON HOSPITAL   (United Kingdom)

Author keywords

Bone mineral density; Fracture threshold; Glucocorticoids; Osteoporosis diagnosis; Vertebral fracture

Indexed keywords

PREDNISOLONE;

ADULT; ARTICLE; BONE DENSITY; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; RISK ASSESSMENT; VERTEBRA FRACTURE;

EID: 0034092021     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2000.15.5.952     Document Type: Article

References (19)

1. Cooper C, Mitchell M, Wickham C 1995 Rheumatoid arthritis, corticosteroid therapy and the risk of hip fracture. Ann Rheum Dis 54:49-52.
2. Spector TD, Hall GM, McCloskey EV, Kanis JA 1993 Risk of vertebral fracture in women with rheumatoid arthritis. BMJ 306:558.
3. Luengo M, Picado C, Del Rio L, Guañabens N, Montserrat JM, Setoain J 1991 Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. Thorax 46:803-806.
4. Peel NFA, Moore DJ, Barrington NA, Bax DE, Eastell R 1995 Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis 54:801-806.
5. World Health Organization 1994 Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organization, Technical Report Series, Geneva, Switzerland.
6. Eastell R, Reid DM, Compston J, Cooper C, Francis RM, Hosking DJ, Purdie DW, Ralston SH, Reeve J, Russell RG, Stevenson JC, Torgerson DJ 1998 A UK consensus group on the management of glucocorticoid-induced osteoporosis: An update. J Intern Med 244:271-292.
7. Adachi JD, Bensen WG, Brown J, Hanley D, Hodsman A, Josse R, Kendler DL, Lentle B, Olszynski W, Ste-Marie LG, Tenenhouse A, Chines AA 1997 Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosi. N Engl J Med 337:382-387.
8. Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, Thamsborg G, Liberman UA, Delmas PD, Malice MP, Czachur M, Daifotis AG 1998 Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-induced osteoporosis intervention study group. N Engl J Med 339:292-299.
9. Steiger P 1995 Standardization of spine BMD measurements. J Bone Miner Res 10:1602-1603 (letter).
10. Walsh LJ, Wong CA, Pringle M, Tattersfield AE 1996 Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: A cross sectional study. 313:344-346.
11. Orwoll ES, Oviatt SK, Mann T 1990 The impact of osteophytic and vascular calcifications on vertebral mineral density measurements in men. J Clin Endocrinol Metab 70:1202-1207.
12. Masud T, Langley S, Wiltshire P, Doyle DV, Spector TD 1993 Effect of spinal osteophytosis on bone mineral density measurements in vertebral osteoporosis. BMJ 307:172-173.
13. Hanson J, Felsenberg D, Fuerst T, Lu Y, Genant HK, Hangartner T, Harrold L, Johnston CC Jr, Kalendar WA, Mazess R, Nord R, Miller PD, Monta R, Nakamura A, Tamegai T, Reeve J, Schiessl H, Tysarczyk-Niemeyer G, Steiger P, Stein J, von Stetten E 1997 Untitled. Bone 21:369-370 (letter).
14. Faulkner KG, Roberts LA, McClung MR 1996 Discrepancies in normative data between Lunar and Hologic DXA systems. Osteoporos Int 6:432-436.
15. Aaron JE, Francis RM, Peacock M, Makins NB 1989 Contrasting microanatomy of idiopathic and corticosteroid-induced osteoporosis. Clin Orthop 243:294-305.
16. Dempster DW 1989 Bone histomorphometry in glucocorticoid-induced osteoporosis. J Bone Miner Res 4:137-141.
17. LoCascio V, Bonucci E, Imbimbo B, Ballanti P, Adami S, Milani S, Tartarotti D, DellaRocca C 1990 Bone loss in response to long-term glucocorticoid therapy. Bone Miner 8:39-51.
18. LoCascio V, Ballanti P, Milani S, Bertoldo F, LoCascio C, Zanolin EM, Bonucci E 1998 A histomorphometric long-term longitudinal study of trabecular bone loss in glucocorticoid-treated patients: Prednisone versus deflazacort. Calcif Tissue Int 62:199-204.
19. Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, et al. 1996 Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study. J Bone Miner Res 11:1531-1538.